Alison M. Schram, Timothy Dudley Clay, Hans Prenen, John J. Park, Lukas Lunger, Joanna Hussain, Daniela Maier, Shigehisa Kitano, Ecaterina Elena Dumbrava, Hyung-Don Kim, Mariano Ponz-Sarvise, Ye Guo. "Beamion PANTUMOR-1: A phase II, multicenter, multicohort, open-label trial to evaluate the efficacy and safety of the oral HER2-selective tyrosine kinase inhibitor zongertinib for the treatment of
            <i>HER2</i>
            -mutated or overexpressed/amplified solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps3187